Sirenda Vong1, Michael O'Leary1, Zijian Feng2. 1. World Health Organization Office in China, 401 Dongwai Diplomatic Office Building, 23 Dongzhimenwai Dajie, Chaoyang District, Beijing 100600, China . 2. Chinese Centre for Disease Control and Prevention, Beijing, China .
Abstract
PROBLEM: In 2003, China's handling of the early stages of the epidemic of severe acute respiratory syndrome (SARS) was heavily criticized and generally considered to be suboptimal. APPROACH: Following the SARS outbreak, China made huge investments to improve surveillance, emergency preparedness and response capacity and strengthen public health institutions. In 2013, the return on these investments was evaluated by investigating China's early response to the emergence of avian influenza A(H7N9) virus in humans. LOCAL SETTING: Clusters of human infection with a novel influenza virus were detected in China - by national surveillance of pneumonia of unknown etiology - on 26 February 2013. RELEVANT CHANGES: On 31 March 2013, China notified the World Health Organization (WHO) of the first recorded human infections with A(H7N9) virus. Poultry markets - which were rapidly identified as a major source of transmission of A(H7N9) to humans - were closed down in the affected areas. Surveillance in humans and poultry was heightened and technical guidelines were quickly updated and disseminated. The health authorities collaborated with WHO in risk assessments and risk communication. New cases were reported promptly and publicly. LESSONS LEARNT: The relevant infrastructures, surveillance systems and response capacity need to be strengthened in preparation for future emergencies caused by emerging or existing disease threats. Results of risk assessments and other data should be released promptly and publicly and such release should not jeopardize future publication of the data in scientific journals. Coordination between public health and veterinary services would be stronger during an emergency if these services had already undertaken joint preparedness planning.
PROBLEM: In 2003, China's handling of the early stages of the epidemic of severe acute respiratory syndrome (SARS) was heavily criticized and generally considered to be suboptimal. APPROACH: Following the SARS outbreak, China made huge investments to improve surveillance, emergency preparedness and response capacity and strengthen public health institutions. In 2013, the return on these investments was evaluated by investigating China's early response to the emergence of avian influenza A(H7N9) virus in humans. LOCAL SETTING: Clusters of human infection with a novel influenza virus were detected in China - by national surveillance of pneumonia of unknown etiology - on 26 February 2013. RELEVANT CHANGES: On 31 March 2013, China notified the World Health Organization (WHO) of the first recorded human infections with A(H7N9) virus. Poultry markets - which were rapidly identified as a major source of transmission of A(H7N9) to humans - were closed down in the affected areas. Surveillance in humans and poultry was heightened and technical guidelines were quickly updated and disseminated. The health authorities collaborated with WHO in risk assessments and risk communication. New cases were reported promptly and publicly. LESSONS LEARNT: The relevant infrastructures, surveillance systems and response capacity need to be strengthened in preparation for future emergencies caused by emerging or existing disease threats. Results of risk assessments and other data should be released promptly and publicly and such release should not jeopardize future publication of the data in scientific journals. Coordination between public health and veterinary services would be stronger during an emergency if these services had already undertaken joint preparedness planning.
Authors: K Subbarao; A Klimov; J Katz; H Regnery; W Lim; H Hall; M Perdue; D Swayne; C Bender; J Huang; M Hemphill; T Rowe; M Shaw; X Xu; K Fukuda; N Cox Journal: Science Date: 1998-01-16 Impact factor: 47.728
Authors: J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen Journal: Lancet Date: 2003-04-19 Impact factor: 79.321
Authors: Dan Feng; Sake J de Vlas; Li-Qun Fang; Xiao-Na Han; Wen-Juan Zhao; Shen Sheng; Hong Yang; Zhong-Wei Jia; Jan Hendrik Richardus; Wu-Chun Cao Journal: Trop Med Int Health Date: 2009-06-05 Impact factor: 2.622
Authors: Longde Wang; Yu Wang; Shuigao Jin; Zunyou Wu; Daniel P Chin; Jeffrey P Koplan; Mary Elizabeth Wilson Journal: Lancet Date: 2008-10-17 Impact factor: 79.321
Authors: Chris Degeling; Jane Johnson; Ian Kerridge; Andrew Wilson; Michael Ward; Cameron Stewart; Gwendolyn Gilbert Journal: BMC Public Health Date: 2015-12-29 Impact factor: 3.295
Authors: Xiaowei Ma; Qiuyan Liao; Jun Yuan; Yufei Liu; Yanhui Liu; Jiandong Chen; Jianping Liu; Wenfeng Cai; Benjamin J Cowling; Biao Di; Richard Fielding; Ming Wang; Zhicong Yang; Gabriel M Leung; Eric H Y Lau Journal: BMC Infect Dis Date: 2014-10-18 Impact factor: 3.090
Authors: Qiuyan Liao; Jun Yuan; Eric H Y Lau; Guang Yan Chen; Zhi Cong Yang; Xiao Wei Ma; Jian Dong Chen; Yan Hui Liu; Chang Wang; Xiao Ping Tang; Yu Fei Liu; Li Zhuo; Gabriel M Leung; Wei Zhang; Benjamin J Cowling; Ming Wang; Richard Fielding Journal: PLoS One Date: 2015-12-01 Impact factor: 3.240
Authors: Jun Yuan; Eric H Y Lau; Kuibiao Li; Y H Connie Leung; Zhicong Yang; Caojun Xie; Yufei Liu; Yanhui Liu; Xiaowei Ma; Jianping Liu; Xiaoquan Li; Kuncai Chen; Lei Luo; Biao Di; Benjamin J Cowling; Xiaoping Tang; Gabriel M Leung; Ming Wang; Malik Peiris Journal: Emerg Infect Dis Date: 2015-10 Impact factor: 6.883